Discontinuation of antiepileptic drugs in patients with calcified neurocysticercosis

Journal of Epilepsy

Volumn 9, Issue 4, 1996, Pages 231-233

  Del Brutto, Oscar H ^a,b   Campos, Xavier ^a  

^a HOSPITAL LUIS VERNAZA   (Ecuador)

^b NONE   (Ecuador)

Author keywords

Antiepileptic drugs; Cerebral calcifications; Neurocysticercosis; Seizure recurrence

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BRAIN CALCIFICATION; BRAIN CYST; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MALE; NEUROCYSTICERCOSIS; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; RELAPSE; SEIZURE; TREATMENT OUTCOME;

EID: 0030460750     PISSN: 08966974     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6974(96)00022-9     Document Type: Article

References (6)

1. 1. Del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 1994;44:1706-9.
2. 2. Kramer LD. Antihelminthic therapy for neurocysticercosis [Letter]. Arch Neurol 1990;47:1059.
3. 3. Del Brutto OH, Sotelo J, Roman GC. Therapy for neurocysticercosis: a reappraisal. Clin Infect Dis 1993;17:730-5.
4. 4. Clarke HB, Gabrielsen TO. Seizure-induced disruption of blood-brain barrier demonstrated by CT. J Comput Assist Tomogr 1989;13:889-97.
5. 5. Vazquez N, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696-701.
6. 6. Del Brutto OH. Medical treatment of cysticercosis - effective. Arch Neurol 1995;52:102-4.